Amgen reported $4.61B in Operating Expenses for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbvie ABBV:US USD 9.62B 590M
Agios Pharmaceuticals AGIO:US USD -24371000 114.53M
ALKERMES ALKS:US USD 325.26M 12.26M
Amgen AMGN:US USD 4.61B 695M
Astrazeneca AZN:US USD 10.11B 376M
Biogen BIIB:US USD 1.84B 650.7M
Biomarin Pharmaceutical BMRN:US USD 562.04M 54.28M
Bluebird Bio BLUE:US USD 84.85M 24.07M
Bristol Myers Squibb BMY:US USD 9.46B 716M
Coherus Biosciences CHRS:US USD 96.84M 29.03M
Eli Lilly And LLY:US USD 5.47B 200.3M
Exelixis EXEL:US USD 472M 142.87M
Genmab GEN:DC DKK 2.56B 406M
Gilead Sciences GILD:US USD 5.12B 917M
GlaxoSmithKline GSK:LN GBP 5.51B 1.13B
Glaxosmithkline GSK:US GBP 5.51B 1.13B
Intercept Pharmaceuticals ICPT:US USD 95.24M 84.25M
IONIS PHARMACEUT IONS:US USD 359.91M 140.99M
Johnson & Johnson JNJ:US USD 19.51B 1.54B
Merk MRK:US USD 10.32B 624M
Mirati Therapeutics MRTX:US USD 212.66M 20.78M
Moderna Inc MRNA:US USD 3.5B 1.31B
Neurocrine Biosciences NBIX:US USD 308.6M 8.5M
Novartis NOVN:VX USD 11.05B 378M
Novartis NVS:US USD 11.05B 378M
Pfizer PFE:US USD 19.12B 5.9B
Ptc Therapeutics PTCT:US USD 367.75M 82.44M
Puma Biotechnology PBYI:US USD 68.02M 13.3M
Regeneron Pharmaceuticals REGN:US USD 2.27B 555.1M
Roche Holding ROG:VX 25.06B 4.31B
Sarepta Therapeutics SRPT:US USD 367.84M 119.23M
Seattle Genetics SGEN:US USD 682.15M 20.95M
Takeda 4502:JP JPY 949.56B 51.69B
Teva Pharmaceutical TEVA:IT USD 4.74B 1.56B
Ultragenyx Pharmaceutical RARE:US USD 248.98M 66.79M
Vertex Pharmaceuticals VRTX:US USD 1.27B 61.6M
YTE INCY:US USD 856.61M 171.68M